Fernando Espi Forcen, MD, PhD

Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Lincoln Residence Program, McLean Hospital, Boston, Massachusetts

  • 3Articles
  • 15.1KReads
  • 2023–2026Active
  • 15Collaborators
  • 10Citations

About

Fernando Espi Forcen, MD, PhD, is affiliated with the Department of Psychiatry at Harvard Medical School and the Lincoln Residence Program at McLean Hospital in Boston, Massachusetts. His publications from 2023 to 2026 focus on the psychiatric and medical aspects of psychedelic use, including psychological adverse effects and complications. He has also explored pharmacotherapy and ketamine-assisted psychotherapy for treatment-resistant depression, with an emphasis on clinical cases involving self-doubt and self-criticism. His work frequently involves collaboration with colleagues such as Brian S. Barnett and Erin Mauney.

Publications

PCC
Psychological Adverse Effects of Psychedelic Use
Rounds in the General Hospital

Psychological Adverse Effects of Psychedelic Use

June 25, 2026

This case-based review explores psychological adverse effects of psychedelic use, covering risk factors, trauma history, phenomenology, and evidence-based management strategies for clinicians.
, , , et al
PCC
Medical Complications of Psychedelics
Rounds in the General Hospital

Medical Complications of Psychedelics

June 23, 2026

This case-based review covers acute complications, drug interactions, and long-term safety across psilocybin, MDMA, ketamine, and ibogaine, with practical guidance for clinicians.
, , , et al
JCP
Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression
Cross Talk: Case Conferences From MGH

Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression

April 5, 2023

A 61-year-old patient with TRD and a history of self-criticism sought ketamine assisted psychotherapy. Experts from diverse therapeutic perspectives discuss this intriguing case.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe